We are live on ! Find out more
DAM

DLD Asset Management Portfolio holdings

AUM $1.51B Turnover 51.11%
1-Year Est. Return 5.32%
This Fund
S&P 500
This Quarter Est. Return
+0.48%
1 Year Est. Return
+5.32%
3 Year Est. Return
+10.27%
5 Year Est. Return
+32.59%
10 Year Est. Return
–
AUM
$1.38B
AUM Growth
+$362M
Cap. Flow
-$348M
Cap. Flow %
-25.31%
Top 10 Hldgs %
62.01%
Holding
142
New
43
Increased
15
Reduced
9
Closed
60
Avg Time Held Equity + Options
0.2 years
Top 10 Avg Time Held Equity + Options
0.4 years
Top 20 Avg Time Held Equity + Options
0.3 years
Avg Time Held Equity only
0.2 years
Top 10 Avg Time Held Equity only
0.4 years
Top 20 Avg Time Held Equity only
0.3 years

Top Buys

Rank Stock Value
1
CTSH icon
Cognizant
CTSH
+$53.1M
2
KSU
Kansas City Southern
KSU
+$31.9M
3
PF
Pinnacle Foods, Inc.
PF
+$27.7M
4
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$5.3M
5
PCRX icon
Pacira BioSciences
PCRX
+$3.43M

Top Sells

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$12.3M
2
INSM icon
Insmed
INSM
+$7.51M
3
NBIX icon
Neurocrine Biosciences
NBIX
+$6.36M
4
DYNC icon
Vistra Energy Corp.
DYNC
+$5.07M
5
NXH icon
Neighborhood Intelligence Inc
NXH
+$3.25M

Sector Composition

Rank Sector Weight
1 Miscellaneous 89.94%
2 Technology 3.93%
3 Industrials 2.49%
4 Consumer Staples 2.13%
5 Healthcare 0.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
PCRX icon
26
Pacira BioSciences
PCRX
$1.45B
$3.95M 0.29%
+86,500
New +$3.43M
2017 Q4
0 quarters
OTIC
27
DELISTED
Otonomy, Inc.
OTIC
$2.83M 0.21%
510,000
+267,400
+110% +$1.16M
2017 Q3
1 quarter
EGOV
28
CALL
DELISTED
NIC Inc
EGOV
$2.42M 0.18%
+146,100
New +$2.47M
2017 Q4
0 quarters
NL icon
29
NLI Holdings
NL
$324M
$1.98M 0.14%
+139,255
New +$1.77M
2017 Q4
0 quarters
IMMR icon
30
CALL
Immersion
IMMR
$236M
$1.97M 0.14%
+279,400
New +$2.02M
2017 Q4
0 quarters
PCRX icon
31
PUT
Pacira BioSciences
PCRX
$1.45B
$1.22M 0.09%
+26,800
New +$1.06M
2017 Q4
0 quarters
CAA
32
DELISTED
CalAtlantic Group, Inc.
CAA
$992K 0.07%
+17,600
New +$860K
2017 Q4
0 quarters
LPCN icon
33
PUT
Lipocine
LPCN
$13.4M
$959K 0.07%
16,406
-7,712
-32% -$480K
2017 Q1
3 quarters
IXYS
34
DELISTED
IXYS Corp
IXYS
$958K 0.07%
40,000
+23,000
+135% +$555K
2017 Q3
1 quarter
STRP
35
DELISTED
Straight Path Communications Inc.
STRP
$880K 0.06%
4,840
+340
+8% +$61.7K
2017 Q3
1 quarter
SNI
36
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
$854K 0.06%
10,000
+1,000
+11% +$82.6K
2017 Q3
1 quarter
TEVA icon
37
CALL
Teva Pharmaceutical Industries Limited
TEVA
$48.6B
$819K 0.06%
43,200
+21,600
+100% +$325K
2017 Q3
1 quarter
TRCO
38
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
$747K 0.05%
17,600
+3,100
+21% +$128K
2017 Q2
2 quarters
INFY icon
39
Infosys
INFY
$49.4B
$702K 0.05%
+86,500
New +$658K
2017 Q4
0 quarters
AET
40
DELISTED
Aetna Inc
AET
$631K 0.05%
+3,500
New +$601K
2017 Q4
0 quarters
AAAP icon
41
DELISTED
Advanced Accelerator Applications S.A.
AAAP
$612K 0.04%
+7,500
New +$582K
2017 Q4
0 quarters
COL
42
DELISTED
Rockwell Collins
COL
$475K 0.03%
+3,500
New +$469K
2017 Q4
0 quarters
DYN icon
43
PUT
DELISTED
Dynegy, Inc.
DYN
$457K 0.03%
38,500
– –
2017 Q2
2 quarters
HSNI
44
DELISTED
HSN, Inc.
HSNI
$426K 0.03%
+10,560
New +$418K
2017 Q4
0 quarters
CAVM
45
DELISTED
Cavium, Inc.
CAVM
$419K 0.03%
+5,000
New +$387K
2017 Q4
0 quarters
LPCN icon
46
Lipocine
LPCN
$13.4M
$409K 0.03%
7,000
-16,606
-70% -$1.03M
2017 Q2
2 quarters
MON
47
DELISTED
Monsanto Co
MON
$409K 0.03%
+3,500
New +$416K
2017 Q4
0 quarters
GNCMA
48
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
$390K 0.03%
10,000
+2,500
+33% +$102K
2017 Q3
1 quarter
CPN
49
DELISTED
Calpine Corporation
CPN
$378K 0.03%
+25,000
New +$375K
2017 Q4
0 quarters
CCC icon
50
DELISTED
Calgon Carbon Corp
CCC
$375K 0.03%
+17,600
New +$378K
2017 Q4
0 quarters
1
2
3 4 5

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.51B AUM 33.02% 1-Year Est. Return
SC
Styrax Capital New York $1.52B AUM 57.44% 1-Year Est. Return
HCM
Hodges Capital Management Dallas, Texas $1.51B AUM 85.85% 1-Year Est. Return
NB
NBT Bank Norwich, New York $1.51B AUM 24.9% 1-Year Est. Return
WFA
Wellspring Financial Advisors Cleveland, Ohio $1.52B AUM 29.68% 1-Year Est. Return
RIM
Rush Island Management New York $1.51B AUM 8.12% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.52B AUM 3.09% 1-Year Est. Return

DLD Asset Management's Q4 2017 Portfolio in Review

As of Q4 2017, DLD Asset Management held 142 positions worth $1.38B, up 36% from $1.02B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

DLD Asset Management withdrew a net $348M in Q4 2017, closing 60 positions and reducing 9 holdings. Its most notable exit was PTC Therapeutics, an estimated $12.3M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 90% of assets, down from 95% a quarter earlier, followed by Technology and Industrials.

Against the trend, DLD Asset Management opened a new position in Cognizant worth $51.6M.

  • DLD Asset Management's largest Q4 2017 buy was Cognizant: 726,740 shares worth $51.6M.
  • DLD Asset Management added most to Otonomy, Inc. in Q4 2017, an estimated $1.16M increase.
  • DLD Asset Management's biggest Q4 2017 reduction was Lipocine, cutting an estimated $1.03M.
  • DLD Asset Management fully exited PTC Therapeutics in Q4 2017, selling an estimated $12.3M.
  • DLD Asset Management's ten largest holdings make up 62% of its $1.38B portfolio in Q4 2017.
  • DLD Asset Management opened 43 new positions and closed 60 in Q4 2017.
  • DLD Asset Management's portfolio value rose 36% quarter-over-quarter to $1.38B.

Based on DLD Asset Management's 13F filing for Q4 2017, filed 12 Feb 2018.